Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma
Clinical trial NCT01808599 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01808599
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.